Skip to main content

Selected Infectious Diseases

Family Medicine

Abstract

The focus of this chapter is on toxoplasmosis, Rocky Mountain spotted fever (RMSF), trichinosis, giardiasis, psittacosis, Ebola virus, Lyme disease, and hantavirus. Most of these illnesses are zoonotic in nature. Physicians should be familiar with their diagnosis, evaluation, and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Schlüter D, Däubener W, Schares G, Groß U, Pleyer U, Lüder C. Animals are key to human toxoplasmosis. Int J Med Microbiol. 2014;304:917. pii: S 1438-4221(14)00118-0.

    Article  PubMed  Google Scholar 

  2. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animal to humans. Int J Parasitol. 2000;30:1217.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Heller HM. Toxoplasmosis in immunocompetent hosts. In: Up to Date Weller PF, (ED). Up-to-date, Waltham, MA Topic 5699 ver 9.0; 2015.

    Google Scholar 

  4. Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F. Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis. 2006;25(11):687.

    Article  CAS  PubMed  Google Scholar 

  5. Dupouy-Camet J, de Souza SL, Maslo C, Paugam A, Saimot AG, Benarous R, Tourte-Schaefer C, Derouin F. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol. 1993;31(7):1866.

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Kaplan S. Current therapies in pediatric infectious disease. 3rd ed. St Louis: Mosby-Year Book; 1993. p. 344–345.

    Google Scholar 

  7. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20(5):1118–21.

    Article  CAS  PubMed  Google Scholar 

  8. Holman RC, McQuiston JH, Haberling DL, Cheek JE. Increasing incidence of Rocky Mountain spotted fever among the American Indian population in the United States. Am J Trop Med Hyg. 2009;80(4):601–5.

    PubMed  Google Scholar 

  9. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, et al. National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995;52(5):405–13.

    CAS  PubMed  Google Scholar 

  10. Alvarez-Hernandez G, Murillo-Benitez C, Del Carmen Candia-Plata M, Moro M. Clinical profile and predictors of fatal rocky Mountain spotted fever in children from Sonora, Mexico. Pediatr Infect Dis J. 2014; 34(2):125–30.

    Google Scholar 

  11. Minniear TD, Buckingham SC. Managing Rocky Mountain spotted fever. Expert Rev Anti Infect Ther. 2009;7(9):1131–7.

    Article  PubMed  Google Scholar 

  12. Sexton DJ, Corey GR. Rocky Mountain “spotless” and “almost spotless” fever: a wolf in sheep’s clothing. Clin Infect Dis. 1992;15(3):439–48.

    Article  CAS  PubMed  Google Scholar 

  13. Helmick CG, Bernard KW, D’Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150(4):480–8.

    Article  CAS  PubMed  Google Scholar 

  14. Doyle A, Bhalla KS, Jones 3rd JM, Ennis DM. Myocardial involvement in Rocky Mountain spotted fever: a case report and review. Am J Med Sci. 2006;332(4):208–10.

    Article  PubMed  Google Scholar 

  15. McQuiston JH, Wiedeman C, Singleton J, Carpenter LR, McElroy K, Mosites E, et al. Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg. 2014;91(4):767–70.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Kaplan JE, Schonberger LB. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg. 1986;35(4):840–4.

    CAS  PubMed  Google Scholar 

  17. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993–1996. Am J Trop Med Hyg. 2000;63(1–2):21–6.

    CAS  PubMed  Google Scholar 

  18. Devleeschauwer B, Praet N, Speybroeck N, Torgerson PR, Haagsma JA, De Smet K, et al. The low global burden of trichinellosis: evidence and implications. Int J Parasitol. 2014;45(2–3):95–9. doi:10.1016/j.ijpara.2014.05.006.

    Google Scholar 

  19. Pozio E, Zarlenga DS. New pieces of the Trichinella puzzle. Int J Parasitol. 2013;43(12–13):983–97.

    Article  PubMed  Google Scholar 

  20. Kennedy ED, Hall RL, Montgomery SP, Pyburn DG, Jones JL, Centers for Disease Control and Prevention (CDC). Trichinellosis surveillance – United States, 2002–2007. MMWR Surveill Summ. 2009;58(9):1–7.

    PubMed  Google Scholar 

  21. Yoder JS, Gargano JW, Wallace RM, Beach MJ. Giardiasis surveillance –United States, 2009–2010. Morb Mortal Wkly Rep CDC Survei Sum. 2012;61(SS-05):12–23.

    Google Scholar 

  22. Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev. 2001;14(3):447–75.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Solaymani-Mohannadis S, Singer SM. Giardia duodenalis the double-edge sword of immune response in giardiasis. Exp Parasitol. 2010;126(3):292–7.

    Article  Google Scholar 

  24. Muhsen K, Levine MM. A systematic review and meta-analysis of the association between Giardia Lamblia and endemic pediatric diarrhea in developing countries. Clin Infect Dis. 2012;55 Suppl 4:S271–93.

    Article  PubMed Central  PubMed  Google Scholar 

  25. McHandy IH, Wu M, Shimizu-Cohen R. Detection of intestinal protozoa in the clinical laboratory. Clin Microbiol. 2014;52(3):712–20. doi:10.1128/JCM.02877-13.

    Google Scholar 

  26. Garden TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001;14(1):114–28.

    Article  Google Scholar 

  27. Funk DJ, Kumar A. Ebola virus disease: an update for anesthesiologists and intensivists. Can J Anaesth. 2014;62(1):80–91. doi:10.1007/s12630-014-0257-z.

    Google Scholar 

  28. Nyenswah T, Fahnbulleh M, Massaquoi M, et al. Ebola epidemic—Liberia, March–October 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1082–6.

    PubMed  Google Scholar 

  29. WHO Ebola Response Team. Ebola virus disease in West Africa – the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481–95.

    Article  PubMed Central  Google Scholar 

  30. Fausther-Bovendo H, Mulangu S, Sullivan NJ. Ebolavirus vaccines for humans and apes. Curr Opin Virol. 2012;2(3):324–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82–115. doi:10.1016/j.jaut.2014.09.004.

    Google Scholar 

  32. Murray TS, Shapiro ED. Lyme disease. Clin Lab Med. 2010;30(1):311–28.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and management of Lyme disease. Amm Fam Physician. 2012;85(11):1086–93.

    Google Scholar 

  34. Biesiada G, Czepiel J, Lesniak MR, Garlicki A, Mach T. Lyme disease: review. Arch Med Sci. 2012;8(6):978–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Dunaj J, Moniuszko A, Zajkowska J, Pancewicz S. The role of PCR in diagnostics of Lyme borreliosis. Przegl Epidemiol. 2013;67:35–9.

    PubMed  Google Scholar 

  36. Vaheri A, Strandin T, Hepojoki J. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol 2013:539–50. Nature.com. Web. http://www.nature.com/nrmicro/journal/v11/n8/full/nrmicro3066.html

  37. Outbreak of hantavirus infection in Yosemite National Park. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. 2012. Web. 15 Jan 2015. http://www.cdc.gov/hantavirus/outbreaks/yosemite-national-park-2012.html

  38. Kruger D, Figueiredo L, Song J-W, Klempa B. Hantaviruses-globally emerging pathogens. J Clin Virol. 2014;88:811. Elsevier.

    Article  Google Scholar 

  39. Holmes EC, Zhang YZ. The evolution and emergence of hantaviruses. Curr Opin Virol. 2014;10:27–33. doi:10.1016/j.coviro.2014.12.007. Elsevier.

    Google Scholar 

  40. Kaya S. Prognostic factors in hantavirus infections. Mikrobiyol Bül. 2014:n. page. National Center for Biotechnology Information. U.S. National Library of Medicine. Web. 15 Jan 2015. http://www.ncbi.nlm.nih.gov/pubmed/24506730

  41. Schmaljon C, Hjelle B. Hantaviruses-globally emerging pathogens. Emerg Infect Dis. 1997;3(2):95–104. National Center for Infectious Diseases, Centers for Disease Control and Prevention

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos A. Arango .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this entry

Cite this entry

Arango, C.A., Shah, N., Nalamalapu, S.R. (2015). Selected Infectious Diseases. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-1-4939-0779-3_46-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_46-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Selected Infectious Diseases
    Published:
    06 July 2020

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_46-2

  2. Original

    Selected Infectious Diseases
    Published:
    05 October 2015

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_46-1